Katsuichi Miyamoto

A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells

Katsuichi Miyamoto, Sachiko Miyake, Takashi Yamamura · Nature · 2001 · 870 citations

Life Sciences, Immunology, Neurology +15

Efficacy of the anti–IL-6 receptor antibody tocilizumab in neuromyelitis optica

M. Araki, Takako Matsuoka, Katsuichi Miyamoto et al. · Neurology · 2014 · 303 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +15

Suppression of collagen‐induced arthritis by natural killer T cell activation with OCH, a sphingosine‐truncated analog of α‐galactosylceramide

Asako Chiba, Shinji Oki, Katsuichi Miyamoto et al. · Arthritis & Rheumatism · 2004 · 168 citations

Life Sciences, Immunology, Pathology +17

Heterogeneity of presenile dementia with bone cysts (Nasu–Hakola disease)

Takayuki Kondo, Kazuya Takahashi, N. Kohara et al. · Neurology · 2002 · 109 citations

Medicine, Geriatric Medicine, Health Sciences +17

Neuropeptide Y (NPY) Suppresses Experimental Autoimmune Encephalomyelitis: NPY1 Receptor-Specific Inhibition of Autoreactive Th1 Responses In Vivo

Sammy Bedoui, Sachiko Miyake, Youwei Lin et al. · The Journal of Immunology · 2003 · 100 citations · Full text

Life Sciences, Immunology, Neuroscience +16